{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:44:54Z","timestamp":1794638694376,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Scientific Research Program","award":["15K09274"],"award-info":[{"award-number":["15K09274"]}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.kint.2019.01.031","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T05:46:56Z","timestamp":1552715216000},"page":"104-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy"],"prefix":"10.1016","volume":"96","author":[{"given":"James R.","family":"Myette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy J.","family":"Szretter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boopathy","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy","family":"Adari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan D.","family":"Deotale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Shriver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Wollacott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.01.031_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: a systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.01.031_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5414\/CNP74372","article-title":"The changing pattern of primary glomerulonephritis in Singapore and other countries over the past 3 decades","volume":"74","author":"Woo","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2019.01.031_bib3","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2019.01.031_bib4","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1172\/JCI74475","article-title":"The genetics and immunobiology of IgA nephropathy","volume":"124","author":"Kiryluk","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.01.031_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ki.2011.501","article-title":"An update on the pathogenesis and treatment of IgA nephropathy","volume":"81","author":"Boyd","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.01.031_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-pathol-011110-130216","article-title":"IgA nephropathy: molecular mechanisms of the disease","volume":"8","author":"Mestecky","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.kint.2019.01.031_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI5535","article-title":"Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies","volume":"104","author":"Tomana","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.01.031_bib8","first-page":"629","article-title":"IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1","volume":"118","author":"Suzuki","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.01.031_bib9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ajpath.2012.06.038","article-title":"Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes","volume":"181","author":"Hashimoto","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2019.01.031_bib10","doi-asserted-by":"crossref","first-page":"e0190967","DOI":"10.1371\/journal.pone.0190967","article-title":"Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy","volume":"13","author":"Placzek","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2019.01.031_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.kint.2019.01.031_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd1982","article-title":"An APRIL to remember: novel TNF ligands as therapeutic targets","volume":"5","author":"Dillon","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.kint.2019.01.031_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri2322","article-title":"The regulation of IgA class switching","volume":"8","author":"Cerutti","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2019.01.031_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cellimm.2015.02.011","volume":"295","author":"Matsuda","year":"2015","journal-title":"Cell Immunol"},{"key":"10.1016\/j.kint.2019.01.031_bib15","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2007-09-110858","article-title":"APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells","volume":"111","author":"Belnoue","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.kint.2019.01.031_bib16","first-page":"1061","article-title":"In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development","volume":"24","author":"Burjanadze","year":"2009","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.kint.2019.01.031_bib17","first-page":"2887","article-title":"APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa","volume":"118","author":"Huard","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.01.031_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ng.1047","article-title":"A\u00a0genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy","volume":"44","author":"Yu","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2019.01.031_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.2966","article-title":"Association of TNFSF13 polymorphisms with IgA nephropathy in a Chinese Han population","volume":"19","author":"Zhong","year":"2017","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.kint.2019.01.031_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2019.01.031_bib21","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1681\/ASN.2015060677","article-title":"The role of TNF superfamily member 13 in the progression of IgA nephropathy","volume":"27","author":"Han","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.01.031_bib22","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1172\/JCI45563","article-title":"Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy","volume":"121","author":"McCarthy","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.01.031_bib23","doi-asserted-by":"crossref","first-page":"e3099","DOI":"10.1097\/MD.0000000000003099","article-title":"Increased APRIL expression induces IgA1 aberrant glycosylation in IgA nephropathy","volume":"95","author":"Zhai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.kint.2019.01.031_bib24","doi-asserted-by":"crossref","first-page":"e0137044","DOI":"10.1371\/journal.pone.0137044","article-title":"Pathogenic role of a proliferation-inducing ligand (APRIL) in murine IgA nephropathy","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2019.01.031_bib25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1681\/ASN.2011121160","article-title":"Development of a model of early-onset IgA nephropathy","volume":"23","author":"Okazaki","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.01.031_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1128\/MCB.24.3.997-1006.2004","article-title":"APRIL-deficient mice have normal immune system development","volume":"24","author":"Varfolomeev","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2019.01.031_bib27","doi-asserted-by":"crossref","unstructured":"Wollacott AM, Robinson LN, Ramakrishnan B, et al. Structural prediction of antibody-APRIL complexes by computational docking constrained by antigen saturation mutagenesis library data [e-pub ahead of print]. J Mol Recognit. https:\/\/doi.org\/10.1002\/jmr.2778. Accessed March 20, 2019.","DOI":"10.1002\/jmr.2778"},{"key":"10.1016\/j.kint.2019.01.031_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2015.06.057","article-title":"Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.kint.2019.01.031_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.coviro.2015.03.019","article-title":"Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization","volume":"11","author":"Viswanathan","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.kint.2019.01.031_bib30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1681\/ASN.2016050496","article-title":"Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy","volume":"28","author":"Muto","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.01.031_bib31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1681\/ASN.2011070701","article-title":"O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis","volume":"23","author":"Otani","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.01.031_bib32","doi-asserted-by":"crossref","first-page":"e1006609","DOI":"10.1371\/journal.pgen.1006609","article-title":"GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway","volume":"13","author":"Kiryluk","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.kint.2019.01.031_bib33","first-page":"197548","article-title":"Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease","volume":"2014","author":"Reily","year":"2014","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.kint.2019.01.031_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-381300-8.00002-2","article-title":"Innate signaling networks in mucosal IgA class switching","volume":"107","author":"Chorny","year":"2010","journal-title":"Adv Immunol"},{"key":"10.1016\/j.kint.2019.01.031_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ekir.2017.02.005","article-title":"What genetics tells us about the pathogenesis of IgA nephropathy: the role of immune factors and infection","volume":"2","author":"Zhang","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2019.01.031_bib36","first-page":"107","article-title":"The confounding effects of loss of excretory renal function and development of non-selective proteinuria on serum biomarker levels and a potential role for B cell\u00a0survival factors in renal progression in IgAN","volume":"4","author":"Wimbury","year":"2018","journal-title":"Kidney Dis"},{"key":"10.1016\/j.kint.2019.01.031_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of\u00a0belimumab in patients with active systemic lupus erythematosus: a\u00a0randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.01.031_bib38","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.01.031_bib39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ki.2012.197","article-title":"The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression","volume":"82","author":"Zhao","year":"2012","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819301747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819301747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:53:44Z","timestamp":1758761624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253819301747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0085253819301747"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.01.031","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736081673.793562893","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}